These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1905907)

  • 1. Inhibition of DNA synthesis and oncogene expression in tumor cells by the biological factor DIF.
    Letnansky K; Vetterlein M; Shi C
    Anticancer Res; 1991; 11(2):981-6. PubMed ID: 1905907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoietin on DNA synthesis, proto-oncogene expression and phospholipase C activity in rat vascular smooth muscle cells.
    Gogusev J; Zhu DL; Hérembert T; Ammarguellat F; Marche P; Drueke T
    Biochem Biophys Res Commun; 1994 Mar; 199(2):977-83. PubMed ID: 8135847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
    Pape KA; Floyd-Smith G
    Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puromycin-elicited c-myc mRNA superinduction precedes apoptosis in HL-60 leukaemic cells.
    Davidoff AN; Mendelow BV
    Anticancer Res; 1993; 13(6A):2257-60. PubMed ID: 8297142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor.
    Gómez-Lechón MJ; Guillén I; Ponsoda X; Fabra R; Trullenque R; Nakamura T; Castell JV
    Hepatology; 1996 May; 23(5):1012-9. PubMed ID: 8621126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
    Heckford SE; Gelmann EP; Matis LA
    Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-252a inhibits the increase in c-fos transcription and the increase in intracellular calcium produced by nerve growth factor in PC12 cells.
    Lazarovici P; Levi BZ; Lelkes PI; Koizumi S; Fujita K; Matsuda Y; Ozato K; Guroff G
    J Neurosci Res; 1989 May; 23(1):1-8. PubMed ID: 2501508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the c-fos gene expression on the mitogenic response in EL2 rat fibroblasts.
    Di Francesco P; Liboi E
    Int J Tissue React; 1988; 10(5):311-9. PubMed ID: 3150759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene expression in thymocytes after emetine treatment of mice.
    Schweighoffer T; Schweighoffer E; Sviresheva M; Apati A; Balogh A; Csuka I; Luat NN; Banfalvi G
    Cell Mol Biol Res; 1993; 39(7):647-56. PubMed ID: 8054999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance.
    Eliot HE; Borner MM; Sinha BK
    Anticancer Res; 1995; 15(3):729-33. PubMed ID: 7645949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C-induced stimulation or inhibition of cellular proliferation in a murine macrophage tumor cell line.
    Goode NT; Moore JP; Hart IR
    Cancer Res; 1990 Mar; 50(6):1828-33. PubMed ID: 2106388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene.
    Sadhu DN; Merchant M; Safe SH; Ramos KS
    Arch Biochem Biophys; 1993 Jan; 300(1):124-31. PubMed ID: 8424644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.